1P-LSD
 
(8β)-N,N-Diethyl-6-methyl-1-propanoyl-9,10-didehydroergoline-8-carboxamide
 5916 ·  C23H29N3O2 ·  379.495
 InChI=1S/C23H29N3O2/c1-5-21(27)26-14-15-12-20-18(17-9-8-10-19(26)22(15)17)11-16(13-24(20)4)23(28)25(6-2)7-3/h8-11,14,16,20H,5-7,12-13H2,1-4H3/t16-,20-/m1/s1
 JSMQOVGXBIDBIE-OXQOHEQNSA-N This stereoisomer Any stereoisomer
 CCN(C(=O)[C@H]1CN(C)[C@H]2C(=C1)c1cccc3c1c(C2)cn3C(=O)CC)CC

Brandt, SD; Kavanagh, PV; Westphal, F; Stratford, A; Elliott, SP; Hoang, K; Wallach, J; Halberstadt, AL. Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Test. Analysis, 1 Sep 2016, 8 (9), 891–902. 1.8 MB. https://doi.org/10.1002/dta.1884

Brandt, SD; Kavanagh, PV; Twamley, B; Westphal, F; Elliott, SP; Wallach, J; Stratford, A; Klein, LM; McCorvy, JD; Nichols, DE; Halberstadt, AL. Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775). Drug Test. Analysis, 1 Feb 2018, 10 (2), 310-322. 1.2 MB. https://doi.org/10.1002/dta.2222

EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, 1 May 2016. 1.0 MB. #22

Halberstadt, AL; Geyer, MA. Effect of hallucinogens on unconditioned behavior. In Behavioral Neurobiology of Psychedelic Drugs; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 1 Jan 2017; pp 159-199. 652 kB. https://doi.org/10.1007/7854_2016_466

1P-MIPLA
13 November 2018 · Creative Commons BY-NC-SA ·